A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines

Journal of Immunology

Volumn 171, Issue 2, 2003, Pages 553-561

  Nagakubo, Daisuke ^a   Murai, Toshiyuki ^a   Tanaka, Toshiyuki ^a   Usui, Takeo ^a   Matsumoto, Masanori ^a   Sekiguchi, Kiyotoshi ^b   Miyasaka, Masayuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOSAMINOGLYCAN; PROTEIN MAC25; RANTES; SCLEROPROTEIN; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0038784523     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.2.553     Document Type: Article

References (41)

1. Kraal, G., and R. E. Mebius. 1997. High endothelial venules: lymphocyte traffic control and controlled traffic. Adv. Immunol. 65:347.
2. Imhof, B. A., and D. Dunon. 1995. Leukocyte migration and adhesion. Adv. Immunol. 58:345.
3. Girard, J. P., and T. A. Springer. 1995. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today 16:449.
4. Izawa, D., T. Tanaka, K. Saito, H. Ogihara, T. Usui, S. Kawamoto, K. Matsubara, K. Okubo, and M. Miyasaka. 1999. Expression profile of active genes in mouse lymph node high endothelial cells. Int. Immunol. 11:1989.
5. + high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker. J. Immunol. 168:1050.
6. Girard, J. P., E. S. Baekkevold, T. Yamanaka, G. Haraldsen, P. Brandtzaeg, and F. Amalric. 1999. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am. J. Pathol. 155:2043.
7. Baxter, R. C., M. A. Binoux, D. R. Clemmons, C. A. Conover, S. L. Drop, J. M. Holly, S. Mohan, Y. Oh, and R. G. Rosenfeld. 1998. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology 139:4036.
8. Collet, C., and J. Candy. 1998. How many insulin-like growth factor binding proteins? Mol. Cell. Endocrinol. 139:1.
9. Hwa, V., Y. Oh, and R. G. Rosenfeld. 1999. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20:761.
10. Akaogi, K., Y. Okabe, J. Sato, Y. Nagashima, H. Yasumitsu, K. Sugahara, and K. Miyazaki. 1996. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93:8384.
11. Sato, J., S. Hasegawa, K. Akaogi, H. Yasumitsu, S. Yamada, K. Sugahara, and K. Miyazaki. 1999. Identification of cell-binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surface. J. Cell. Biochem. 75:187.
12. Kishibe, J., S. Yamada, Y. Okada, J. Sato, A. Ito, K. Miyazaki, and K. Sugahara. 2000. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells. J. Biol. Chem. 275:15321.
13. Yamauchi, T., F. Umeda, M. Masakado, M. Isaji, S. Mizushima, and H. Nawata. 1994. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem. J. 303:591.
14. Hata, Y., A. Clermont, T. Yamauchi, E. A. Pierce, I. Suzuma, H. Kagokawa, H. Yoshikawa, G. S. Robinson, T. Ishibashi, T. Hashimoto, et al. 2000. Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. J. Clin. Invest. 106:541.
15. Nagira, M., T. Imai, K. Hieshima, J. Kusuda, M. Ridanpää, S. Takagi, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie. 1997. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J. Biol. Chem. 272:19518.
16. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95:258.
17. Baekkevold, E. S., T. Yamanaka, R. T. Palframan, H. S. Carlsen, F. P. Reinholt, U. H. von Andrian, P. Brandtzaeg, and G. Haraldsen. 2001. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193:1105.
18. Pelletier, A. J., L. J. W. van der Laan, P. Hildbrand, M. A. Siani, D. A. Thompson, P. E. Dawson, B. E. Torbett, and D. R. Salomon. 2000. Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells. Blood 96:2682.
19. Oh, Y., S. R. Nagalla, Y. Yamanaka, H. S. Kim, E. Wilson, and R. G. Rosenfeld. 1996. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7: recombinant human mac25 protein specifically binds IGF-I and -II. J. Biol. Chem. 271:30322.
20. Kato, M. V. 2000. A secreted tumor-suppressor, mac25, with activin-binding activity. Mol. Med. 6:126.
21. Usui, T., T. Murai, T. Tanaka, K. Yamaguchi, D. Nagakubo, C. M. Lee, M. Kiyomi, S. Tamura, Y. Matsuzawa, and M. Miyasaka. 2002. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int. Immunol. 14:1273.
22. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30.
23. Imai, T., T. Yoshida, M. Baba, M. Nishimura, M. Kakizaki, and O. Yoshie. 1996. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 271:21514.
24. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963.
25. 1 integrins. J. Biol. Chem. 276:17550.
26. 1. J. Biol. Chem. 273:15854.
27. Hirose, J., H. Kawashima, O. Yoshie, K. Tashiro, and M. Miyasaka. 2001. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 276:5228.
28. Streeter, P. R., B. T. Rouse, and E. C. Butcher. 1988. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J. Cell Biol. 107:1853.
29. Sugiura, N., K. Sakurai, Y. Hori, K. Karasawa, S. Suzuki, and K. Kimata. 1993. Preparation of lipid-derivatized glycosaminoglycans to probe a regulatory function of the carbohydrate moieties of proteoglycans in cell-matrix interaction. J. Biol. Chem. 268:15779.
30. Ezaki, T., L. Yao, and K. Matsuno. 1995. The identification of proliferating cell nuclear antigen (PCNA) on rat tissue cryosections and its application to double immunostaining with other markers. Arch. Histol. Cytol. 58:103.
31. Olsen, B.R., and Y. Ninomiya. 1999. Collagens: overview of the family. In Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins, 2nd Ed. T. Kreis and R. Vale, eds. Oxford University Press, Oxford, U.K., p. 380.
32. Miner, J. H., B. L. Patton, S. I. Lentz, D. J. Gilbert, W. D. Snider, N. A. Jenkins, N. G. Copeland, and J. R. Sanes. 1997. The laminin α chains: expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J. Cell Biol. 137:685.
33. Frieser, M., H. Nöckel, F. Pausch, C. Röder, A. Hahn, R. Deutzmann, and L. M. Sorokin. 1997. Cloning of the mouse laminin α4 cDNA: expression in a subset of endothelium. Eur. J. Biochem. 246:727.
34. Sorokin, L. M., F. Pausch, M. Frieser, S. Kröger, E. Ohage, and R. Deutzmann. 1997. Developmental regulation of the laminin α5 chain suggests a role in epithelial and endothelial cell maturation. Dev. Biol. 189:285.
35. Stevens, R. L., M. M. Kamada, and W. E. Serafin. 1989. Structure and function of the family of proteoglycans that reside in the secretory granules of natural killer cells and other effector cells of the immune response. Curr. Top. Microbiol. Immunol. 140:93.
36. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immun. 2:102.
37. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immun. 2:123.
38. Anderson, A. O., and S. Shaw. 1993. T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Semin. Immunol. 5:271.
39. Anderson, N. D., A. O. Anderson, and R. G. Wyllie. 1976. Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunology 31:455.
40. Herman, P. G., I. Yamamoto, and H. Z. Mellins. 1972. Blood microcirculation in the lymph node during the primary immune response. J. Exp. Med. 136:697.
41. Kawashima, H., K. Atarashi, M. Hirose, J. Hirose, S. Yamada, K. Sugahara, and M. Miyasaka. 2002. Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277:12921.